Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/12/2014 | CN103623404A Haemophilus influenzac type B polysaccharide conjugate vaccine preparation method |
03/12/2014 | CN103145818B Rice OsAT1 protein as well as coding gene and application thereof |
03/12/2014 | CN103145817B Sickle-alfalfa chloroplast cold-response protein (MfcpCOR14) and coding gene and application thereof |
03/12/2014 | CN103102401B Application of GmMYB73 in cultivating stress tolerance transgenic plants |
03/12/2014 | CN103102400B Soybean transcription active protein GmPHD6, and coding gene and application thereof |
03/12/2014 | CN103087160B Flagellum motor protein, coding gene thereof, and applications thereof |
03/12/2014 | CN102952181B Fluorescence sensor protein, related plasmid and encoding gene and preparation method thereof |
03/12/2014 | CN102836420B Methods and compositions involving MDA-7 |
03/12/2014 | CN102786591B Technology for synthesizing metallothionein through orient induction |
03/12/2014 | CN102776202B Cultivation method of male sterile plant |
03/12/2014 | CN102775488B Colorectal cancer specific antigen peptide and colorectal cancer detection kit |
03/12/2014 | CN102731632B Recombinant ganoderma immunomodulatory protein monomethoxypolyglycol succinimidyl propionate modifier, preparation method and use thereof |
03/12/2014 | CN102665754B Immunomodulating polypeptides derived from IL-2 and use thereof in cancer and chronic infections |
03/12/2014 | CN102584947B Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
03/12/2014 | CN102558326B Transcription factor MxIRO2, coding gene thereof, and application thereof |
03/12/2014 | CN102477093B Preparation method of thermal-stable human keratinocyte growth factor mutant and application of preparation method |
03/12/2014 | CN102311957B Hydatidovis soluble antigen preparation method and product thereof |
03/12/2014 | CN102268451B Human insulin gene-containing expression vector and construction method and application thereof |
03/12/2014 | CN102112146B Immunity inducer |
03/12/2014 | CN102065881B Stable amyloid BETA monomers and oligomers |
03/12/2014 | CN101998965B Immunosuppressive polypeptides and nucleic acid |
03/12/2014 | CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity |
03/12/2014 | CN101861521B High sensitivty immunoassays and kits for determination of peptides and proteins of biological interest |
03/12/2014 | CN101796415B Novel liver cancer marker |
03/12/2014 | CN101541960B Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing same |
03/12/2014 | CN101460054B Mature dendritic cell compositions and methods for culturing same |
03/12/2014 | CN101261277B Promyostatin peptides and methods of using same |
03/11/2014 | US8669417 Methods and compositions for increasing plant transformation efficiency |
03/11/2014 | US8669353 Process for producing milk fractions rich in secretory immunoglobulins |
03/11/2014 | US8669348 Anti diabetic protein |
03/11/2014 | US8669347 Truncated variant of the mammalian target for rapamycin (MTOR) protein |
03/11/2014 | US8669345 Nogo receptor antagonists |
03/11/2014 | US8669231 Activation of peptide prodrugs by hK2 |
03/11/2014 | US8669228 Glucagon analogs exhibiting enhanced solubility in physiological pH buffers |
03/11/2014 | US8669227 Fast-acting insulin formulation |
03/11/2014 | US8669225 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
03/11/2014 | US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein |
03/11/2014 | US8669092 Urocortin-III and uses thereof |
03/11/2014 | US8669074 Chimeric phosphorylation indicator |
03/11/2014 | US8669066 Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays |
03/11/2014 | US8669051 Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system |
03/11/2014 | US8669050 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
03/11/2014 | CA2612458C Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry |
03/11/2014 | CA2591235C Process for preparing high levels of interferon beta |
03/11/2014 | CA2567449C Antibodies and related molecules that bind to psca proteins |
03/11/2014 | CA2566620C Vaccine against hpv16 and hpv18 and at least another hpv type slected from hpv 31, 45 or 52 |
03/11/2014 | CA2558829C Methods for treating viral infection using il-28 and il-29 cysteine mutants |
03/11/2014 | CA2531684C Binding molecules against sars-coronavirus and uses thereof |
03/11/2014 | CA2501851C Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
03/11/2014 | CA2459862C Oxyntomodulin for preventing or treating excess weight |
03/11/2014 | CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
03/11/2014 | CA2375912C Immunotherapy of autoimmune disorders using antibodies which target b-cells |
03/07/2014 | CA2809647A1 Erythropoietin receptor modified electrode and its preparation method and application |
03/06/2014 | WO2014036492A1 Modified amino acids comprising an azido group |
03/06/2014 | WO2014036482A2 Novel coelenterazine compounds and methods of use |
03/06/2014 | WO2014036468A2 Aav mediated aquaporin gene transer to treat sjogren's syndrome |
03/06/2014 | WO2014036238A1 Axmi-234 and axmi-235 toxin genes and methods for their use |
03/06/2014 | WO2014036213A1 Astexin peptides |
03/06/2014 | WO2014036048A1 Long intergenic non-coding rnas in maize |
03/06/2014 | WO2014035989A1 Flagellin fusion proteins and methods of use |
03/06/2014 | WO2014035364A2 Gelatin alkyd peptides and uses thereof |
03/06/2014 | WO2014035361A1 IL-1β INHIBITOR COMPOSITION AND USE THEREOF |
03/06/2014 | WO2014035289A1 A pharmaceutical composition for stimulation of angiogenesis |
03/06/2014 | WO2014034754A1 Psf1-derived peptide |
03/06/2014 | WO2014034046A1 Vaccine formulation against toxoplasma gondii infection |
03/06/2014 | WO2014033714A1 Isolated polynucleotides, polypeptides and methods of using same for increasing abiotic stress tolerance, biomass and yield of plants |
03/06/2014 | WO2014033540A2 Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof |
03/06/2014 | WO2014033281A1 Methods and peptides for preventing and treating a bcr-abl and a c-abl associated disease |
03/06/2014 | WO2014033193A1 Stabilised proteins for immunising against staphylococcus aureus |
03/06/2014 | WO2014033192A1 Stabilised proteins for immunising against staphylococcus aureus |
03/06/2014 | WO2014033191A1 Stabilised proteins for immunising against staphylococcus aureus |
03/06/2014 | WO2014033149A1 Marker vaccine |
03/06/2014 | WO2014032402A1 Erythropoietin recovery method |
03/06/2014 | WO2014009808A3 Lipidated peptides as anti-obesity agents |
03/06/2014 | WO2014009733A3 Therapeutic targets for alzheimer's disease |
03/06/2014 | WO2014009589A3 Use of nuclear localization signals of bacteriophage proteins as gene transfer vehicle |
03/06/2014 | WO2013179062A3 Assays |
03/06/2014 | WO2013179044A3 Cladosporium peptides |
03/06/2014 | WO2013151767A8 Therapy for kidney disease and/or heart failure by intradermal infusion |
03/06/2014 | WO2013088368A3 Use of the mmp-12 protein in the prevention and/or treatment of aged or senescent skin |
03/06/2014 | WO2012106377A3 Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof |
03/06/2014 | US20140066694 Immobilized bioactive hydrogel matrices as surface coatings |
03/06/2014 | US20140066623 Ribosome Structure and Protein Synthesis Inhibitors |
03/06/2014 | US20140066607 Method for isolating osteopontin using concentrated feeds |
03/06/2014 | US20140066606 Production of high mannose glycosylated proteins stored in the plastid of microalgae |
03/06/2014 | US20140066598 Modified Amino Acids |
03/06/2014 | US20140066597 Preparation of canola protein isolate and use in aquaculture |
03/06/2014 | US20140066596 Isolated egg protein and egg lipid materials, and methods for producing the same |
03/06/2014 | US20140066595 Modulators of Protein Production in a Human Cell Line and Cell-free Extracts Produced Therefrom |
03/06/2014 | US20140066387 Functionalized biomaterials for tissue regeneration |
03/06/2014 | US20140066384 Novel genes and proteins that home to developing microvessels |
03/06/2014 | US20140066382 Autophagy-Inducing Peptide |
03/06/2014 | US20140066379 Recombinant vector, transgenic fish egg using the same and biomaterial using the same |
03/06/2014 | US20140066378 Multivalent Heteromultimer Scaffold Design and Constructs |
03/06/2014 | US20140066375 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer |
03/06/2014 | US20140066370 Polypeptide Conjugate |
03/06/2014 | US20140065724 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
03/06/2014 | US20140065711 Small molecule-dependent inteins and uses thereof |
03/06/2014 | US20140065695 Peptides and methods for inducing cell death |
03/06/2014 | US20140065673 Membrane protein expression vector comprising major envelope protein p9 of systovirus phi12 as a fusion partner and method for producing membrane protein using the same |